prestige bio pbp1510 cancer
Scope
Date
~
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Life Science invests in US biotech firm Latus Bio
Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...
May 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima, Herzuma to Peru
South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...
May 02, 2024 (Gmt+09:00)
-
Private equity
Daesung PE tops Korean venture funds by return in 2018-2023
Daesung Private Equity Inc. in South Korea has become the top local venture capital manager in terms of realized capital gain between 2018 and 2023,...
Apr 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Bio startup ArtBlood attracts $4.8 mn investment
South Korean bio startup ArtBlood, specializing in blood production for transfusion, announced on Tuesday that it successfully secured an investment...
Apr 09, 2024 (Gmt+09:00)
-
Fiber & Textile
Hyosung TNC to invest $1 bn in new bio-fiber plants in Vietnam
Hyosung TNC Corp., the world’s top spandex maker, plans to invest $1 billion in new bio-textile materials plants in Vietnam to accelerate its ...
Apr 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Mar 24, 2024 (Gmt+09:00)
-
Corporate restructuring
LG Chem reshuffles R&D unit to turn into EV materials maker
LG Chem Ltd., South Korea’s largest petrochemical company, is strengthening its research & development capabilities as it aims to transfor...
Mar 18, 2024 (Gmt+09:00)
-
Artificial intelligence
LG, Jackson Lab to jointly develop AI models for Alzheimer’s, cancers
LG AI Research, the artificial intelligence research arm of South Korea’s LG Group, and the Jackson Laboratory (JAX), a US non-profit biomedic...
Mar 11, 2024 (Gmt+09:00)
-
Chemical Industry
HD Hyundai Chemical to produce eco-friendly bio-naphtha
South Korea's HD Hyundai Chemical Co. announced on Thursday that it will collaborate with CJ CheilJedang Corp. to produce eco-friendly bio-naphtha...
Mar 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung targets gene therapy sector through US investments
Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...
Feb 27, 2024 (Gmt+09:00)
-
Chemical Industry
LG Chem, CJ CheilJedang to launch eco-friendly bio-nylon joint venture
South Korea’s top chemicals maker LG Chem Ltd. and food and biotechnology firm CJ CheilJedang Corp. have agreed to launch an eco-friendly bio-...
Feb 15, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Beauty & Cosmetics
Cosmax opens integrated R&D center for bio-material
Cosmax Group, South Korea's largest cosmetics manufacturer specializing in original design manufacturing (ODM), announced on Monday that it has la...
Feb 05, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion, WuXi XDC to develop new antibody-drug conjugates
South Korea’s Celltrion Inc. has signed a business agreement with China’s WuXi XDC to jointly develop new antibody-drug conjugates (ADC)...
Jan 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Biopharma M&As: Next big thing for South Korean manufacturers
When Orion Corp., known for its signature snack cake Choco-Pie, announced a $415 million deal to acquire biotech startup LegoChem Biosciences Inc. l...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Roche to use Biodyne’s tech for cervical cancer diagnostic kits
Roche, a Swiss multinational healthcare company, is set to use a South Korean company’s technology for cervical cancer diagnostic kits.Biodyne...
Jan 16, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lunit acquires NZ-based AI diagnostics firm Volpara
South Korean medical AI company Lunit announced on Thursday that it will acquire New Zealand-based AI breast cancer diagnostics solutions company Vo...
Dec 14, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Corporate strategy
Samsung launches new growth engine control tower at mobile division
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, has created a business control tower within its Digital eX...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio mulls name change after defeat to Lego
South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Access Bio opens second plant in New Jersey
The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...
Dec 04, 2023 (Gmt+09:00)